Search

Your search keyword '"Lias, Amelia M."' showing total 18 results

Search Constraints

Start Over You searched for: Author "Lias, Amelia M." Remove constraint Author: "Lias, Amelia M."
18 results on '"Lias, Amelia M."'

Search Results

2. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

3. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype

5. Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

6. Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

7. The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites

8. Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

9. The Dual Action of Human Antibodies Specific toPlasmodium falciparumPfRH5 and PfCyRPA: Blocking Invasion and Inactivating Extracellular Merozoites

10. Impact of a blood-stage vaccine on Plasmodium vivax malaria

11. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

12. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

13. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

14. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

15. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

16. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

17. Vaccination with Plasmodium vivaxDuffy-binding protein inhibits parasite growth during controlled human malaria infection

18. Impact of a blood-stage vaccine on Plasmodium vivax malaria.

Catalog

Books, media, physical & digital resources